Longitudinal analysis of adaptive immunity following additional SARS-CoV-2 vaccination in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators
Multiple Sclerosis Journal
; 28(1_SUPPL):85-85, 2022.
Article
in English
| Web of Science | ID: covidwho-1866090
Search on Google
Collection:
Databases of international organizations
Database:
Web of Science
Type of study:
Prognostic study
Topics:
Vaccines
Language:
English
Journal:
Multiple Sclerosis Journal
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS